SCHEMBL6329705

SCHEMBL6329705

[CH2]Cc1ccc(-n2cnc(-c3ccccc3)c2-c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.53
PTGS2 P35354 4/20 0.43
LMNA P02545 2/20 0.41
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 2/20 0.41
MITF O75030 1/20 0.41
NSD3 Q9BZ95 1/20 0.41
PTGS1 P23219 1/20 0.41
MAPK13 O15264 3/20 0.40
MAPK12 P53778 3/20 0.40
MAPK11 Q15759 3/20 0.40
MAPK14 Q16539 3/20 0.40
TSHR P16473 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
FRK P42685 1/20 0.38
MAPK9 P45984 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CSNK1D P48730 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720398 0.84 FAAH (0.56) FAAHPTGS2LMNAALDH1A1SMN1; SMN2
SCHEMBL28304784 0.80 FAAH (0.53) FAAHPTGS2LMNAALDH1A1SMN1; SMN2
SCHEMBL28111191 0.80 FAAH (0.53) FAAHPTGS2LMNAALDH1A1SMN1; SMN2
SCHEMBL27595420 0.80 MAPK14 (0.59) FAAHPTGS2LMNAALDH1A1SMN1; SMN2
SCHEMBL27639359 0.80 FAAH (0.56) FAAHPTGS2LMNAALDH1A1SMN1; SMN2
SCHEMBL28237520 0.77 FAAH (0.67) FAAHPTGS2LMNAALDH1A1SMN1; SMN2
SCHEMBL27595419 0.76 FAAH (0.67) FAAHPTGS2LMNAALDH1A1SMN1; SMN2
SCHEMBL29290491 0.76 FAAH (0.53) FAAHPTGS2LMNAALDH1A1SMN1; SMN2
SCHEMBL28874979 0.73 MAPK13 (0.44) FAAHPTGS2LMNANSD3MAPK13
SCHEMBL14124512 0.72 HTT (0.58) FAAHPTGS2LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6956050-B2 Imidazole compounds as anti-inflammatory and analgesic agents PFIZER, INC. (US) 2005-10-18 US disclosed
US-20030220372-A1 Imidazole compounds as anti-inflammatory and analgesic agents HIRANO MISATO (JP) 2003-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220372-A1 Imidazole compounds as anti-inflammatory and analgesic agents PTGS1, PTGS2, PTGES FAAH 203/4885PTGS2 2/4885LMNA 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.